Integra LifeSciences (IART) Reports Mixed Q2 Earnings; Revises Q3/Q4/FY08 Guidance
Tweet Send to a Friend
Integra LifeSciences Holdings Corporation (Nasdaq: IART) reports Q2 adj-EPS of $0.49, 3 cents better than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
